![]() is engaged in developing, manufacturing, and supplying diagnostic products, medical imaging systems, and surgical products. (South Africa).įounded in 1985 and headquartered in Massachusetts, U.S., Hologic, Inc. (Japan), and Abbott Rapid Diagnostics (PTY) LTD. ![]() (China), Abbott Diagnostics GmbH (Germany), Abbott Diagnostics Medical Co., Ltd. (U.S.), Abbott Point of Care Canada Limited (Canada), Abbott Diagnostics (Shanghai) Co., Ltd. (Japan), Alere Medical Private Limited (India), Murex Diagnostics, Inc. Some of its subsidiaries are Abbott Diagnostics Medical Co., Ltd. The company has its R&D facilities in the U.S., China, Colombia, India, Singapore, Spain, and the U.K. The company operates through its 90 manufacturing facilities across the globe, of which 24 are for diagnostic product manufacturing. ![]() The Diagnostic Products segment offers a broad line of diagnostic systems and tests for blood banks, hospitals, commercial laboratories, clinics, physicians’ offices, retailers, government agencies, alternate care testing sites, and plasma protein therapeutic firms globally.Ībbott has a geographic presence across Germany, Japan, India, Switzerland, Russia, France, Brazil, Italy, the U.K., the U.S., the Netherlands, Colombia, Vietnam, and other countries. The company offers molecular diagnostics products through its Diagnostics business segment. The company has four reportable business segments, namely, Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company has 23 manufacturing sites and 29 research and development sites.įounded in 1888 and headquartered in Illinois, U.S., Abbott Laboratories is engaged in discovering, developing, manufacturing, and marketing a broad range of healthcare products. Roche has a presence in the U.S., Germany, Switzerland, Japan, China, India, New Zealand, Australia, Latin America, and Africa. ![]() The company’s global portfolio includes oncology, virology, microbiology, and blood screening tests for researchers, physicians, patients, hospitals, laboratories, and blood banks. Roche Molecular Diagnostics (RMD), a part of Roche headquartered in California, U.S., develops, manufactures, and supplies a wide range of molecular diagnostics products. The company offers molecular diagnostic products through the Molecular Lab segment. The Diagnostics division is further segmented into Core Lab, Molecular Lab, Point of Care, Diabetes Care, and Pathology Lab. The company has two reportable business divisions, namely, Pharmaceuticals and Diagnostics. Hoffmann-La Roche, commonly called Roche, is a healthcare company that develops, manufactures, and markets a wide range of healthcare solutions. Here are the top 10 companies operating in the Molecular Diagnostics Marketįounded in 1896 and headquartered in Basel, Switzerland, F. Moreover, the growing scope in emerging countries, increasing focus on companion diagnostics and the rising popularity of direct-to-consumer (DTC) genetic testing is expected to create growth opportunities for the Molecular Diagnostics Market. The factors such as the rising global geriatric population, the increasing prevalence of communicable and non-communicable diseases, technological advancements in molecular diagnostics, and rising healthcare expenditures are driving the Molecular Diagnostics Market. More recently, sequencing is an alternative molecular diagnostic technology that will be used widely in the coming years. Polymerase chain reaction (PCR) and microarray technology offer high throughput and more accurate tests. Molecular diagnostics comprises advanced products and technologies used by skilled professionals to improve patient health. During the COVID-19 pandemic, molecular diagnostics played a major role in providing accurate and faster diagnostic results. Advancements in molecular diagnostics have led to personalized healthcare, precision medicine, and predictive healthcare. The Molecular Diagnostics Market Will Register a CAGR of 5.6% during the Forecast Period to Reach $46.69 Billion by 2030, Says “Meticulous Research ®.” Molecular diagnostics is the process of accessing a person’s health at the molecular level by analyzing specific genetic sequences.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |